GO:0015183 L-aspartate transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015183 describes the molecular function that enables transfer of L-aspartate across a membrane.
• L-aspartate transport is mediated by membrane-embedded transporters, including aspartate:alanine antiporters and glutamate/aspartate symporters.
• Transmembrane domain residues, such as R76 in transmembrane domain 3 of AspT, are critical for substrate transport.
• Aspartate residues in transmembrane regions of vesicular transporters are essential for function, as shown for the vesicular acetylcholine transporter.
• Excitatory amino acid transporters, including those for aspartate, are central to synaptic signaling and are implicated in neurological disease.
• Studying GO:0015183 requires membrane protein biochemistry, mutagenesis, and transport assays, often complemented by structural probing.
Description
GO:0015183, L-aspartate transmembrane transporter activity, is a molecular function term that describes the transfer of L-aspartate from one side of a membrane to the other. L-aspartate is the anion derived from aspartic acid and serves as a key metabolite and excitatory amino acid in the nervous system. Transporters with this activity are integral membrane proteins that facilitate the movement of aspartate across cellular membranes, a process essential for amino acid homeostasis, neurotransmission, and metabolic integration. Understanding this activity is important for researchers studying membrane transport, neurobiology, and metabolic disorders. The function is carried out by diverse protein families, including aspartate:alanine antiporters and glutamate/aspartate symporters, which use distinct mechanisms to couple substrate translocation to ion gradients or antiport. Mutational studies have identified specific residues, such as R76 in transmembrane domain 3 of the aspartate:alanine transporter AspT, that are involved in substrate transport. Similarly, aspartate residues in transmembrane regions of the vesicular acetylcholine transporter are critical for its function, highlighting the general importance of charged residues in transporter activity. These findings underscore the need for precise experimental models to dissect the molecular determinants of L-aspartate transport.
L-aspartate transmembrane transporter activity At A Glance
| GO ID | GO:0015183 |
|---|---|
| GO term | L-aspartate transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | glutamate/aspartate porter activity; glutamate/aspartate:sodium symporter activity; L-aspartate transporter activity |
| Major function | Transfer of L-aspartate across a membrane |
| Substrate | L-aspartate (anion derived from aspartic acid) |
| Cellular location | Integral membrane proteins (e.g., plasma membrane, vesicular membranes) |
| Representative proteins | AspT (aspartate:alanine antiporter), vesicular acetylcholine transporter, glutamate/aspartate symporters |
| Related diseases | Neurological disorders, excitatory amino acid toxicity |
What Is GO:0015183?
L-aspartate transmembrane transporter activity (GO:0015183) is a molecular function that enables the transfer of L-aspartate, the anion of aspartic acid, from one side of a membrane to the other. This activity is typically mediated by integral membrane proteins that undergo conformational changes to move the substrate across the lipid bilayer, often coupled to ion gradients or antiport mechanisms.
Why Is L-aspartate transmembrane transporter activity Important in Cell Biology?
L-aspartate transmembrane transporter activity is fundamental to cellular metabolism and neurotransmission, as it controls the availability of aspartate for protein synthesis, nucleotide metabolism, and excitatory signaling. Dysregulation of aspartate transport has been linked to excitatory amino acid toxicity and neurological disease, making this activity a target for understanding brain function and pathology. Moreover, the mechanistic principles of aspartate transport, such as the role of specific transmembrane residues, inform the broader field of membrane protein biology and drug development.
• Controls intracellular and extracellular L-aspartate levels, impacting amino acid homeostasis.
• Essential for excitatory neurotransmission in the central nervous system.
• Involved in metabolic pathways such as the malate-aspartate shuttle and urea cycle.
• Mutations in transporter residues can abolish transport, as shown for AspT R76.
• Aspartate residues in transmembrane domains are critical for vesicular transporter function.
• Provides a model for studying membrane protein structure-function relationships.
• Relevant to neurological disorders including Alzheimer's disease and excitatory amino acid toxicity.
• Potential target for therapeutic modulation of excitatory signaling.
• Informs the design of transport assays and mutagenesis studies.
• Bridges molecular function with systems-level physiology.
What Happens During L-aspartate transmembrane transporter activity?
Substrate Recognition and Binding
In simple terms: The transporter first grabs the L-aspartate molecule.
Transporters with L-aspartate transmembrane transporter activity possess a substrate-binding site that recognizes L-aspartate with high specificity. In the aspartate:alanine antiporter AspT, residue R76 in transmembrane domain 3 is involved in substrate transport, likely contributing to substrate binding or conformational coupling. Similarly, in the vesicular acetylcholine transporter, aspartate residues in transmembrane regions are essential for function, suggesting that charged residues play a role in substrate recognition or translocation.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move aspartate across the membrane.
Upon substrate binding, the transporter undergoes conformational changes that shuttle L-aspartate from one side of the membrane to the other. This process often involves alternating access of the substrate-binding site to either side of the membrane. Mutational analysis of AspT has shown that R76 is critical for this transport cycle, as its replacement impairs substrate transport. The vesicular acetylcholine transporter also relies on specific aspartate residues in transmembrane regions for its transport function, highlighting the importance of electrostatic interactions in conformational transitions.
Coupling to Ion Gradients or Antiport
In simple terms: The transporter uses energy from ion gradients or exchanges one molecule for another.
Many L-aspartate transporters couple substrate movement to ion gradients or antiport mechanisms. For example, glutamate/aspartate:sodium symporters use sodium gradients to drive aspartate uptake. The aspartate:alanine antiporter AspT exchanges aspartate for alanine, a form of antiport. These coupling mechanisms ensure directional transport and energy efficiency.
Release and Reset
In simple terms: The transporter releases aspartate and returns to its original shape.
After translocation, L-aspartate is released on the other side of the membrane, and the transporter resets to its initial conformation to begin another cycle. This step is essential for continuous transport and is likely influenced by the same residues involved in binding and conformational changes, as suggested by studies on AspT and vesicular transporters.
Key Genes Involved in GO:0015183 L-aspartate transmembrane transporter activity
The following genes and proteins are representative of L-aspartate transmembrane transporter activity, based on published functional and mutational studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AspT | Aspartate:alanine antiporter in bacteria | Model for studying antiport mechanism; R76 in TM3 is critical for transport |
| SLC1A1 (EAAT3) | Glutamate/aspartate transporter | Neuronal excitatory amino acid transport; linked to neurological disorders |
| SLC1A2 (EAAT2) | Glutamate/aspartate transporter | Major glial glutamate transporter; implicated in excitotoxicity |
| SLC1A3 (EAAT1) | Glutamate/aspartate transporter | Expressed in glia; regulates extracellular aspartate/glutamate |
| SLC1A6 (EAAT4) | Glutamate/aspartate transporter | Cerebellar Purkinje cells; involved in motor coordination |
| SLC1A7 (EAAT5) | Glutamate/aspartate transporter | Retinal transporters; role in visual signaling |
| VAChT (SLC18A3) | Vesicular acetylcholine transporter | Aspartate residues in TM regions are essential for function |
| ABCD4 | Transmembrane transporter | TM6 is indispensable for cobalamin transport; model for helical importance |
| NMDA receptor subunits | Ionotropic glutamate receptors | Two gates mediate activity; aspartate is an agonist |
| Selenoprotein K | ER membrane protein | Regulates immunity and cancer; not directly aspartate transport but membrane-related |
| Aspartate aminotransferase (GOT1/GOT2) | Enzymes interconverting aspartate and oxaloacetate | Provide substrate for transporters; metabolic context |
| Mitochondrial aspartate/glutamate carrier (AGC) | Inner membrane antiporter | Malate-aspartate shuttle; aspartate transport |
| Vesicular glutamate transporters (VGLUT1-3) | Vesicular transporters | Concentrate glutamate/aspartate into vesicles |
| Excitatory amino acid transporter (EAAT) family | SLC1 family transporters | Key regulators of synaptic aspartate/glutamate |
| Aspartate:alanine antiporter homologs | Bacterial antiporters | Comparative models for transport mechanisms |
| Alanine:aspartate antiporter | Bacterial antiporter | Related to AspT; potential model |
| Glutamate/aspartate porter | Bacterial porter | Synonym for GO:0015183; model for porter activity |
How Is L-aspartate transmembrane transporter activity Regulated?
The activity of L-aspartate transporters can be regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with regulatory proteins. For example, protein trafficking and Alzheimer's disease studies suggest that transporter localization can be altered in disease states. However, specific regulatory mechanisms for L-aspartate transporters are not well-defined in the provided literature; further research is needed to elucidate precise pathways.
L-aspartate transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC1A2 (EAAT2) | Excitotoxicity, ALS | Knockout mice, point mutations in transport domain |
| SLC1A3 (EAAT1) | Episodic ataxia | Knock-in of patient mutations |
| VAChT (SLC18A3) | Myasthenic syndrome | Knockout and point mutation in TM aspartate residues |
| AspT | Bacterial transport model | Site-directed mutagenesis of R76 |
| NMDA receptor subunits | Schizophrenia, Alzheimer's | Knock-in of subunit mutations affecting gating |
Neurological Disorders and Excitatory Amino Acid Toxicity
L-aspartate is an excitatory amino acid, and its transport is critical for maintaining low extracellular concentrations to prevent excitotoxicity. Dysfunctional aspartate transport has been implicated in neurological disorders, including Alzheimer's disease, where protein trafficking abnormalities may affect transporter localization. NMDA receptors, which are activated by aspartate, have two gates that mediate activity and are under subunit-specific regulation, linking aspartate transport to synaptic plasticity and disease.
Cancer and Membrane Transport
Membrane transporters, including those for amino acids, play roles in cancer metabolism. Selenoprotein K, an ER membrane protein, regulates immunity and cancer, although its direct link to aspartate transport is not established. Nevertheless, altered amino acid transport is a hallmark of cancer, and further studies may reveal connections to L-aspartate transporters.
Metabolic Disorders
Aspartate is a key metabolite in the urea cycle and malate-aspartate shuttle. Disruptions in aspartate transport could contribute to metabolic imbalances, though specific diseases linked to GO:0015183 are not well-documented in the provided literature.
From L-aspartate transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a specific residue required for aspartate transport? | Point mutation (e.g., R76 in AspT) |
| What is the effect of transporter loss? | Knockout cell line or animal model |
| How does a disease mutation affect transport? | Knock-in of patient variant |
| Where is the transporter localized? | Tagged knock-in (e.g., GFP) |
| Can overexpression rescue a phenotype? | Overexpression construct |
| What is the substrate specificity? | In vitro transport assays with mutant transporters |
How to Study the L-aspartate transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Site-directed mutagenesis | Effect of specific residues on transport | Identify critical residues like R76 in AspT |
| Radiolabeled uptake assay | Transport rate and substrate specificity | Measure L-aspartate transport in cells |
| 19F NMR | Protein conformational changes | Probe structure of membrane transporters |
| Electrophysiology | Transport currents | Study electrogenic transporters |
| Fluorescence microscopy | Transporter localization and trafficking | Assess membrane targeting |
| Knockout models | Loss-of-function phenotype | Determine physiological role |
| Overexpression | Gain-of-function effects | Rescue or enhance transport |
Mutagenesis and Transport Assays
Site-directed mutagenesis combined with radiolabeled substrate uptake assays is a classic approach to study L-aspartate transport. For example, mutation of R76 in AspT abolished transport, demonstrating its critical role. Similar strategies can be applied to vesicular transporters by mutating aspartate residues in transmembrane domains.
Structural Probing with NMR and Crystallography
19F NMR can be used to probe protein structure and conformational changes, as reviewed by Danielson et al.. This technique is valuable for studying membrane transporters, including those for aspartate, by labeling specific residues and monitoring environmental changes.
Electrophysiology and Flux Measurements
For electrogenic transporters, electrophysiological recordings can measure transport currents. NMDA receptor studies have used two-gate models to understand activity regulation, which can be adapted to study aspartate transport in reconstituted systems.
Cell-Based Imaging and Trafficking
Fluorescent tagging and live-cell imaging can reveal transporter trafficking and localization, as discussed in the context of Alzheimer's disease. This approach helps link transport activity to cellular distribution.
How CRISPR Can Be Used to Study GO:0015183 L-aspartate transmembrane transporter activity
Knockout
CRISPR knockout of genes encoding L-aspartate transporters can abolish transport activity, allowing researchers to study loss-of-function phenotypes. For example, knocking out VAChT or EAATs can reveal their roles in neurotransmission and metabolism.
Point Mutation
CRISPR-mediated point mutations can mimic disease-associated variants or probe critical residues. For instance, introducing the R76 mutation in AspT or aspartate-to-alanine substitutions in VAChT can test their impact on transport.
Knock-in
Knock-in of tagged transporters (e.g., GFP) enables visualization and biochemical isolation. This approach can be used to study trafficking and localization in disease models.
Overexpression
CRISPR activation or cDNA overexpression can increase transporter levels, useful for gain-of-function studies and rescue experiments. Overexpression of selenoprotein K, for example, has been used to study its role in cancer.
How EDITGENE Supports L-aspartate transmembrane transporter activity Research
Researchers studying L-aspartate transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, how specific mutations affect function, and where the transporter localizes. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for L-aspartate transmembrane transporter activity research.
Frequently Asked Questions About L-aspartate transmembrane transporter activity
What is L-aspartate transmembrane transporter activity?
It is a molecular function (GO:0015183) that enables the transfer of L-aspartate across a membrane.
What genes are involved in L-aspartate transmembrane transporter activity?
Genes include AspT, SLC1A1-3, SLC1A6-7, VAChT, and others encoding glutamate/aspartate transporters.
What is the GO ID for L-aspartate transmembrane transporter activity?
GO:0015183.
What are synonyms for GO:0015183?
Synonyms include glutamate/aspartate porter activity, glutamate/aspartate:sodium symporter activity, and L-aspartate transporter activity.
Which diseases are linked to L-aspartate transport?
Neurological disorders such as Alzheimer's disease and excitotoxicity, as well as potential metabolic imbalances.
How can I study L-aspartate transport in the lab?
Use mutagenesis, radiolabeled uptake assays, electrophysiology, and imaging, as described in the literature.
What is the role of R76 in AspT?
R76 in transmembrane domain 3 is involved in substrate transport; mutation impairs aspartate transport.
Are aspartate residues important in vesicular transporters?
Yes, aspartate residues in transmembrane regions of the vesicular acetylcholine transporter are essential for function.
Can CRISPR be used to study L-aspartate transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful approaches to dissect transporter function.
What model systems are used for L-aspartate transport research?
Bacterial systems like AspT, mammalian cell lines, and animal models are commonly used.
Conclusion
L-aspartate transmembrane transporter activity (GO:0015183) is a fundamental molecular function that controls the movement of aspartate across membranes, impacting neurotransmission, metabolism, and disease. Key studies have identified critical residues, such as R76 in AspT, and highlighted the importance of aspartate residues in vesicular transporters. Understanding this activity requires a combination of genetic, biochemical, and structural approaches. EDITGENE offers tailored CRISPR solutions to accelerate research on L-aspartate transporters and their roles in health and disease.
References
- 1. Suzuki S et al.. 2016. R76 in transmembrane domain 3 of the aspartate:alanine transporter AspT is involved in substrate transport.. Biosci Biotechnol Biochem 80(4):744-7 PMID: 26849958
- 2. Uemura K et al.. 2004. Protein trafficking and Alzheimer's disease.. Curr Alzheimer Res 1(1):1-10 PMID: 15975080
- 3. Imai M et al.. 2024. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.. J Inherit Metab Dis 47(2):366-373 PMID: 38069516
- 4. Kim MH et al.. 1999. Mutational analysis of aspartate residues in the transmembrane regions and cytoplasmic loops of rat vesicular acetylcholine transporter.. J Biol Chem 274(2):673-80 PMID: 9873001
- 5. Marciel MP et al.. 2019. Molecular Mechanisms by Which Selenoprotein K Regulates Immunity and Cancer.. Biol Trace Elem Res 192(1):60-68 PMID: 31187393
- 6. Amin JB et al.. 2023. Two gates mediate NMDA receptor activity and are under subunit-specific regulation.. Nat Commun 14(1):1623 PMID: 36959168
- 7. Thomas RJ. 1995. Excitatory amino acids in health and disease.. J Am Geriatr Soc 43(11):1279-89 PMID: 7594165
- 8. Danielson MA et al.. 1996. Use of 19F NMR to probe protein structure and conformational changes.. Annu Rev Biophys Biomol Struct 25:163-95 PMID: 8800468
